A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects

Clinical trial NCT01232413 · COMPLETED

Trial details

NCT number: NCT01232413
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Cardiac Repolarization

Start date: 2010-09-01
Primary completion: 2011-02-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.